TCMP
CVS icon

Thrive Capital Management (Pennsylvania)’s CVS Health CVS Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$698K Buy
9,715
+588
+6% +$45.3K 0.15% 117
2025
Q4 		$724K Sell
9,127
-1,004
-10% -$79.2K 0.16% 113
2025
Q3 		$764K Sell
10,131
-381
-4% -$26.1K 0.2% 112
2025
Q2 		$725K Buy
+10,512
New +$689K 0.23% 109
2024
Q1 		– Sell
-2,533
Closed -$200K – 136
2023
Q4 		$200K Sell
2,533
-60
-2% -$4.27K 0.11% 151
2023
Q3 		$209K Buy
+2,593
New +$184K 0.12% 131
2023
Q1 		– Sell
-2,578
Closed -$240K – 123
2022
Q4 		$240K Sell
2,578
-16
-0.6% -$1.54K 0.16% 100
2022
Q3 		$247K Sell
2,594
-101
-4% -$10K 0.17% 95
2022
Q2 		$250K Sell
2,695
-97
-3% -$9.47K 0.17% 90
2022
Q1 		$283K Sell
2,792
-6,999
-71% -$735K 0.17% 77
2021
Q4 		$1.01M Sell
9,791
-10,638
-52% -$983K 0.66% 39
2021
Q3 		$1.73M Buy
20,429
+2,469
+14% +$207K 1.28% 19
2021
Q2 		$1.5M Buy
17,960
+5,610
+45% +$459K 1.17% 24
2021
Q1 		$929K Buy
12,350
+3,651
+42% +$266K 0.87% 30
2020
Q4 		$594K Buy
+8,699
New +$566K 0.63% 37

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Thrive Capital Management (Pennsylvania)'s CVS Position: Q1 2026 in Review

Thrive Capital Management (Pennsylvania) increased its CVS Health (CVS) stake by 6.4% in Q1 2026, buying an estimated $45.3K and bringing the position to 9,715 shares worth $698K. The position accounts for 0.15% of the portfolio, ranked #117.

Thrive Capital Management (Pennsylvania) first reported a position in CVS in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.73M in Q3 2021. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Thrive Capital Management (Pennsylvania) held 9,715 shares of CVS Health worth $698K as of Q1 2026.
  • Thrive Capital Management (Pennsylvania) bought 588 CVS Health shares in Q1 2026, an estimated $45.3K.
  • CVS Health made up 0.15% of Thrive Capital Management (Pennsylvania)'s portfolio in Q1 2026, its #117 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in CVS Health in Q4 2020 and has held it in 15 quarters since.
  • Thrive Capital Management (Pennsylvania)'s CVS Health position peaked at $1.73M in Q3 2021.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q1 2026, filed 27 Apr 2026.